Topic
Remibrutinib
Topic counter · /remibrutinib
Remibrutinib
1 piece on this counter
· 2 min
FDA Approves Novartis' Rhapsido as First Pill for Symptomatic Dermographism
Novartis' Rhapsido (remibrutinib) won FDA approval as the first treatment for symptomatic dermographism. The BTK inhibitor showed 29.3% complete response vs 14…